On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayDec 06, 2023 3:36 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Filing of Landmark Federal Spoofing Lawsuit

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its filing of a complaint in the United States District Court for the Southern District of New York alleging that UBS Securities, LLC, IMC Financial Markets and Clear Street Markets, LLC (the “Defendants”) engaged in a market manipulation scheme that violated Section 10(b) and Rule 10b-5(a) and (c) and Section 9(a) of the Securities Exchange Act of 1934. The lawsuit alleges that between Nov. 9, 2021, and Nov. 9, 2023, the Defendants and/or their customers used spoofing to manipulate the market price of Mullen shares. “In the 21…

Continue Reading

WednesdayDec 06, 2023 2:16 pm

NetworkNewsBreaks – SuperCom Ltd.’s (NASDAQ: SPCB) Proprietary Solutions Gaining Traction Across the US

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and cybersecurity sectors, today announced that it has secured a new contract with a prominent Kentucky -based service provider of electronic monitoring (“EM”) products and services. The contract marks another valuable step in SuperCom’s expansion within the U.S. and progression in the deployment of its newest proprietary technologies: the new PureOne GPS bracelet and domestic violence (“DV”) monitoring solutions. “We are proud to see our new proprietary solutions gaining traction in new regions in the U.S., reaffirming our commitment to innovation and excellence in the field of…

Continue Reading

WednesdayDec 06, 2023 2:10 pm

NetworkNewsBreaks – Nextech3D.ai (CSE: NTAR) (OTCQX: NEXCF) (FSE: EP2) Obtains Potentially Game-Changing AI Tool

Nextech3D.AI (CSE: NTAR) (OTCQX: NEXCF) (FSE: EP2), a generative AI-powered 3D model supplier for Amazon, P&G, Kohl’s and other major e-commerce retailers, today announced receipt of a new AI-tool from Amazon, its largest customer. According to the announcement, Nextech3D.AI is integrating the tool into its production pipeline to speed up the quality assessment (“QA”) for 3D models. “We are gratified and thrilled that Amazon has given us access to this AI quality assessment tool. I see this tool as a game changer for our 3D model production for Amazon,” said Nextech3D.ai CEO Evan Gappelberg. “This AI-powered technology will increase our…

Continue Reading

WednesdayDec 06, 2023 1:53 pm

NetworkNewsBreaks – Sustain Southern California Names IBN as Media Sponsor for Upcoming Sustainability Private Capital Event

Sustain Southern California (Sustain SoCal), a nonprofit organization, announced that InvestorBrandNetwork (“IBN”), a leading corporate communications firm and content distributor, will be the official media sponsor for the sixth annual Sustainability Private Capital Event. The event, scheduled for Dec. 6–7, 2023, will be hosted by Sustain SoCal and Roth MKM. The conference agenda features some 40 companies as well as experts from an array of sectors, including solar/storage, e-mobility, smart cities, circular economy and water, with most of the companies being in the series A/B fundraising stage. Participating investors include venture capitalists, private equity offices, family offices, representatives of endowments…

Continue Reading

WednesdayDec 06, 2023 1:43 pm

NetworkNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CEO Featured in Just-Released Fireside Chat Video

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has released a fireside chat video with CEO and chair Howard Weisman. During the company update video, Weisman outlines the company’s recent achievement and reiterates PaxMedica’s focus on developing groundbreaking therapies and transformative solutions. Specifically, Weisman provided a summary of the company’s Oct. 25, 2023, FDA Type-B meeting, including the regulatory pathway for HAT-PAX-101. He also discussed the company’s successful $7 million public offering and the recent acquisition of suramin research assets from Rediscovery Life Sciences (“RLS”) as well as provided updates on the phase 3 trial…

Continue Reading

WednesdayDec 06, 2023 1:32 pm

NetworkNewsBreaks — Astiva Health Partners with IBN to Deliver Corporate Communications, Increase Awareness

Astiva Health, a leading healthcare provider that specializes in delivering personalized and comprehensive healthcare solutions to diverse communities, has selected IBN, a versatile financial news and publishing company specializing in private and public entities, as a corporate communications partner. According to the announcement, the partnership is designed to enhance Astiva Health's corporate communications initiatives as the company focuses on its mission to deliver unparalleled quality care and establish enduring relationships within the community. Astiva Health is building a reputation for offering comprehensive healthcare solutions to diverse communities, with services rooted in a commitment to community-based healthcare and customized benefit packages aimed at…

Continue Reading

WednesdayDec 06, 2023 1:16 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Interim Analysis on Global Berubicin Trial Showing Promising Results

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. In September, the company announced that 200 out of 243 expected patients had been enrolled in its ongoing study evaluating the effectiveness of Berubicin for recurrent glioblastoma (“GBM”), a highly aggressive and incurable form of brain cancer. The critical and adaptive global trial involves multiple centers and is open-label, randomized and controlled, comparing Berubicin to Lomustine - the standard of care - in adult patients with recurrent GBM (“WHO Grade IV”) after standard first-line therapy has failed. The…

Continue Reading

WednesdayDec 06, 2023 10:27 am

NetworkNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Secures Project with Prominent Swiss Aviation Vendor

HUB Cyber Security (NASDAQ: HUBC), a developer of confidential computing cybersecurity solutions and services, today announced that it has agreed to provide services in connection with a framework agreement with a prominent Swiss aviation vendor. The initial scope is approximately EURO 15.5 million, with potential expansions over the next three years. Under the agreement, HUB is to provide a wide range of solutions and services for cyber data security alongside ongoing systems safety and reliability analysis. “Once again, this vote of confidence validates our core technology and we look forward to additional wins and announcements in the near future,” said…

Continue Reading

TuesdayDec 05, 2023 4:47 pm

NetworkNewsBreaks – Treasure Global Inc. (NASDAQ: TGL) Secures $4.0M in Underwritten Public Offering

Treasure Global (NASDAQ: TGL) recently closed its previously announced underwritten public offering of 26,014,000 shares of common stock, par value $ $0.00001 per share, at a public offering price of $0.10 per share, and 14,000,000 pre-funded warrants, each with a right to purchase one share of common stock at a public offering price of $0.0999 per pre-funded warrant. Aggregate gross proceeds to the company totaled approximately $4.0 million, prior to deducting underwriting discounts and other offering expenses. In addition, Treasure Global granted the underwriters a 45-day option to purchase up to an additional 6,002,100 shares of common stock at the…

Continue Reading

TuesdayDec 05, 2023 4:42 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Closes Non-Brokered Private Placement

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) today announced that it has closed a non-brokered private placement and issued 24 class A multiple voting shares of the company, each at a price of $1.90, for gross proceeds of $45.60 (the “offering”). All securities issued pursuant to the offering are subject to a statutory hold period of four months plus a day from issuance in accordance with applicable securities laws of Canada. FSD Pharma intends to use the proceeds of the offering for general working capital purposes. To view the full press release, visit https://nnw.fm/zR2qL About FSD Pharma Inc. FSD…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217